During the past decade, Columbia University Naomi Berrie Diabetes Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Columbia University Naomi Berrie Diabetes Center" #1 sponsor was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 6 trials, followed by "AstraZeneca" with 3 trials sponsored, "Jaeb Center for Health Research" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored and "GRADE Study Group" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia University Naomi Berrie Diabetes Center" #1 collaborator was "Juvenile Diabetes Research Foundation" with 4 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "The Leona M. and Harry B. Helmsley Charitable Trust" with 3 trials as a collaborator and "American Diabetes Association" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Columbia University Naomi Berrie Diabetes Center" are "Type 1 Diabetes Mellitus" (5 trials), "Diabetes Mellitus, Type 1" (4 trials), "Type 2 Diabetes" (2 trials), "Comparative Effectiveness of Glycemia-lowering Medications" (1 trials) and "Diabetes Mellitus, Non-Insulin-Dependent" (1 trials). Many other conditions were trialed in "Columbia University Naomi Berrie Diabetes Center" in a lesser frequency.

Most popular intervention types in "Columbia University Naomi Berrie Diabetes Center" are "Drug" (9 trials), "Other" (4 trials), "Device" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AC2993" (3 trials), "500mg oral insulin crystals every other week" (1 trials), "67.5 mg oral insulin crystals daily" (1 trials) and "Anti-Thymocyte Globulin (ATG)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University Naomi Berrie Diabetes Center" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Columbia University Naomi Berrie Diabetes Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Columbia University Naomi Berrie Diabetes Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University Naomi Berrie Diabetes Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Columbia University Naomi Berrie Diabetes Center has several departments that took part in Clinical trials: "Naomi Berrie Diabetes Center, Columbia University, 1150 St. Nicholas Ave" - 2 trials